Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 10:49AM ET
80.18
Dollar change
+0.72
Percentage change
0.91
%
IndexS&P 500 P/E- EPS (ttm)-10.07 Insider Own10.09% Shs Outstand254.97M Perf Week-1.06%
Market Cap20.47B Forward P/E18.42 EPS next Y4.35 Insider Trans0.00% Shs Float229.53M Perf Month1.44%
Income-2567.00M PEG- EPS next Q1.29 Inst Own84.27% Short Float1.93% Perf Quarter8.94%
Sales11.48B P/S1.78 EPS this Y12.11% Inst Trans-0.77% Short Ratio2.33 Perf Half Y19.30%
Book/sh66.51 P/B1.21 EPS next Y16.22% ROA-7.73% Short Interest4.44M Perf Year-15.92%
Cash/sh2.78 P/C28.87 EPS next 5Y-6.18% ROE-15.88% 52W Range62.11 - 97.49 Perf YTD-0.98%
Dividend Est.1.99 (2.48%) P/FCF21.99 EPS past 5Y- ROI-10.77% 52W High-17.76% Beta1.24
Dividend TTM3.24 (4.04%) Quick Ratio1.02 Sales past 5Y31.28% Gross Margin26.14% 52W Low29.09% ATR (14)2.18
Dividend Ex-DateDec 27, 2023 Current Ratio1.67 EPS Y/Y TTM-39.51% Oper. Margin6.86% RSI (14)50.00 Volatility3.13% 2.40%
Employees24600 Debt/Eq0.69 Sales Y/Y TTM-7.73% Profit Margin-22.36% Recom2.48 Target Price82.51
Option/ShortYes / Yes LT Debt/Eq0.63 EPS Q/Q-86839.83% Payout- Rel Volume0.99 Prev Close79.46
Sales Surprise0.15% EPS Surprise-4.71% Sales Q/Q-4.96% EarningsFeb 20 AMC Avg Volume1.91M Price80.18
SMA20-0.78% SMA50-0.03% SMA2006.06% Trades Volume455,677 Change0.91%
Date Action Analyst Rating Change Price Target Change
Jan-22-24Upgrade Morgan Stanley Equal-Weight → Overweight $81 → $90
Jan-12-24Upgrade Jefferies Hold → Buy $73 → $112
Nov-28-23Upgrade Argus Hold → Buy
Nov-13-23Downgrade UBS Buy → Neutral $88 → $78
Oct-12-23Initiated Redburn Atlantic Neutral $60
Aug-24-23Downgrade Morgan Stanley Overweight → Equal-Weight $112 → $75
Aug-09-23Downgrade Goldman Buy → Neutral $120 → $78
Aug-08-23Downgrade Stifel Buy → Hold $123 → $85
Aug-08-23Downgrade Societe Generale Buy → Hold $80
Jun-14-23Initiated Citigroup Neutral $84
Feb-22-24 10:01AM
05:40AM
Feb-21-24 11:14PM
12:06PM
11:24AM
06:00PM Loading…
Feb-20-24 06:00PM
04:52PM
04:39PM
04:15PM
11:21AM
Feb-16-24 12:01PM
Feb-15-24 04:00AM
Feb-14-24 09:15AM
Feb-13-24 06:15PM
Feb-06-24 10:19PM
06:15PM Loading…
Feb-05-24 06:15PM
Jan-29-24 06:15PM
Jan-24-24 04:15PM
Jan-19-24 06:55AM
Jan-15-24 01:14AM
Jan-11-24 06:23PM
05:10PM
04:15PM
Dec-26-23 07:48PM
05:02AM
Dec-20-23 11:36AM
Dec-19-23 10:00AM
03:00AM
Dec-08-23 11:24AM
Dec-07-23 12:03PM
11:30AM Loading…
Dec-06-23 11:30AM
Nov-21-23 06:22PM
Nov-16-23 09:00AM
Nov-08-23 10:00PM
02:48PM
01:50AM
Nov-07-23 02:05PM
01:04PM
11:08AM
Nov-06-23 06:30PM
05:50PM
05:17PM
05:14PM
04:52PM
04:16PM
04:15PM
Nov-03-23 09:39AM
09:00AM
07:15AM
Nov-02-23 04:15PM
10:00AM
Nov-01-23 06:15PM
10:29AM
Oct-30-23 05:37PM
11:44AM
10:00AM
02:02AM
01:50AM
01:27AM
01:00AM
Oct-25-23 06:15PM
Oct-24-23 04:15PM
09:00AM
Oct-23-23 04:54PM
04:35PM
Oct-19-23 03:00AM
Oct-18-23 05:24AM
Oct-10-23 12:05PM
Oct-09-23 10:00PM
Oct-04-23 09:00AM
Sep-28-23 09:00AM
Sep-27-23 09:00AM
Sep-20-23 12:43PM
12:03PM
11:32AM
Sep-19-23 11:00AM
Sep-15-23 12:32PM
12:02PM
Sep-13-23 08:12PM
Sep-12-23 06:15PM
Sep-07-23 12:42PM
11:30AM
Sep-06-23 11:30AM
Sep-01-23 12:32PM
Aug-28-23 09:39AM
Aug-24-23 09:57AM
Aug-23-23 05:26AM
Aug-22-23 05:53PM
11:32AM
Aug-21-23 04:15PM
Aug-17-23 11:41AM
Aug-15-23 09:00AM
Aug-14-23 04:49PM
Aug-11-23 06:02AM
Aug-10-23 02:45AM
Aug-09-23 03:33PM
12:09PM
Aug-08-23 05:21PM
03:29PM
01:16PM
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Strzelecki AngelaPresident, Pharma SolutionsJan 03Option Exercise0.001,34107,418Jan 04 04:06 PM
Finzel RalfEVP, Global Operations OfficerDec 01Option Exercise0.005,38705,387Dec 04 04:17 PM
Johnson Jennifer AmyEVP, General CounselNov 01Option Exercise0.001,04105,459Nov 03 04:12 PM
Yildiz BerilCAO, SVP & ControllerOct 03Option Exercise0.001,07701,077Oct 05 04:09 PM
RICHTER GLENN RCFOOct 02Option Exercise0.0011,812023,624Oct 04 04:08 PM
Borg DeborahEVP, Chief HR and D&I OfficerSep 01Option Exercise0.0027,614027,614Sep 06 05:24 PM
Fauchon de Villeplee ChristophPresident, ScentMay 11Sale86.351,972170,2829,093May 12 04:17 PM
Costa Mark JDirectorMay 04Option Exercise0.004680468May 05 08:20 PM
O'Byrne KevinDirectorMay 04Option Exercise0.002620262May 05 07:36 PM
Willoughby Dawn CDirectorMay 04Option Exercise0.004340434May 05 07:36 PM
Gold Christina ADirectorMay 04Option Exercise0.001,24509,169May 05 07:35 PM
Hu GaoxiangDirectorMay 04Option Exercise0.004340434May 05 07:35 PM
Bruno Barry A.DirectorMay 04Option Exercise0.001,24501,534May 05 07:31 PM
Yep Gregory LEVP, Chief Scientific OfficerApr 06Option Exercise0.002,66506,501May 05 09:43 PM
Fauchon de Villeplee ChristophPresident, ScentApr 06Option Exercise0.002,101011,065Apr 10 08:34 PM
Herriott SimonPresident Health & BiosciencesApr 01Option Exercise0.001,48906,894Apr 05 04:08 PM
Clyburn FrankChief Executive OfficerMar 01Option Exercise0.001,32301,323Mar 02 04:38 PM